Journey Medical Corp
DERM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001867066
No open-market purchases or sales by Journey Medical Corp insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $75.2M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Journey Medical Corp changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 77 | 1 | 72 | −4 |
| Shares | 11.0M | 764.1K | 11.9M | +1.61M (+15.7%) |
| Value | $85.0M | $5.89M | $55.8M | −$23.3M (−29.5%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Journey Medical Corp at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 1,082,080 | $5.07M | 0.00% |
| Vanguard Fiduciary Trust Co | 137,706 | $645.8K | 0.00% |
| Vanguard Portfolio Management LLC | 122,245 | $573.3K | 0.00% |
| Frec Markets, Inc. | 50,500 | $236.8K | 0.04% |
| Prelude Capital Management, LLC | 29,894 | $140.2K | 0.01% |
| Trexquant Investment LP | 28,096 | $131.8K | 0.00% |
| Squarepoint Ops LLC | 16,398 | $76.9K | 0.00% |
| Brighton Jones LLC | 12,436 | $58.3K | 0.00% |
| MetLife Investment Management | 12,431 | $58.3K | 0.00% |
| Price T Rowe Associates Inc | 11,215 | $53.0K | 0.00% |
| Cetera Investment Advisers | 10,225 | $48.0K | 0.00% |
| Vanguard Global Advisers, LLC | 4,642 | $21.8K | 0.00% |
| Root Financial Partners, LLC | 2 | $9 | 0.00% |
Sold out (17)
Institutions that held Journey Medical Corp at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Essex Investment Management Co LLC | 345,977 | $2.67M |
| Legato Capital Management LLC | 111,695 | $861.2K |
| SEI Investments Co | 109,351 | $843.1K |
| EAM Investors, LLC | 89,389 | $689.2K |
| Citadel Advisors LLC | 69,415 | $535.2K |
| Geneos Wealth Management Inc. | 63,280 | $487.9K |
| AQR Capital Management LLC | 51,270 | $395.3K |
| Creative Planning | 50,510 | $389.4K |
| Jump Financial, LLC | 20,183 | $155.6K |
| Marshall Wace, LLP | 19,401 | $149.6K |
| Occudo Quantitative Strategies LP | 18,913 | $145.8K |
| SJS Investment Consulting Inc. | 15,000 | $115.7K |
| Jane Street Group, LLC | 13,957 | $107.6K |
| Titleist Asset Management, LLC | 12,900 | $99.5K |
| Simplex Trading, LLC | 434 | $3.35K |
| Amalgamated Bank | 452 | $3.00K |
| Federation des caisses Desjardins du Quebec | 300 | $2.31K |
Not filed for Q1 2026 yet (1)
Institutions that held Journey Medical Corp at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 764,147 | $5.89M |